Anbio Biotechnology (NASDAQ:NNNN) Shares Up 8.6% – Time to Buy?

Anbio Biotechnology (NASDAQ:NNNN)’s stock price traded up 8.6% on Friday . The stock traded as high as $30.49 and last traded at $29.92. 24,754 shares were traded during trading, a decline of 62% from the average session volume of 64,592 shares. The stock had previously closed at $27.55.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, February 9th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, Anbio Biotechnology presently has a consensus rating of “Hold”.

Anbio Biotechnology Stock Performance

Anbio Biotechnology (NASDAQ:NNNN) last announced its earnings results on Tuesday, December 30th. The company reported $0.04 earnings per share (EPS) for the quarter. The business had revenue of $2.29 million for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.